Your Window Into the Innovation Economy

The blood thinner Heparin is administered to about 12 million patients in the U.S. each year to prevent the formation of blood clots during surgical procedures. However, about 1% to 3% of those administered the drug develop Heparin‐induced thrombocytopenia (HIT), a potentially devastating adverse reaction caused by the emergence of antibodies that activate platelets. HIT is a life-threatening complication with a 25% to 30% mortality rate.

Over the past one hundred fifty years, surgery has advanced from operating theaters illuminated by oil lanterns to state-of-the-art facilities utilizing robotic arms performing procedures with superhuman dexterity. Despite these advancements, medical error is responsible for more than a quarter of a million deaths a year in the United States, surpassed only by cancer and heart disease.

Radar technology was invented in the 1930s to detect, locate, track, and recognize various objects via electromagnetic waves. Since then, radar has long been at the forefront of many historical milestones, such as detecting and tracking aircraft and ships during WWII and measuring weather conditions such as wind speeds and ice conditions.

We’re pleased to highlight GigLabs, one of the first investments sourced by our Blockchain Fund team and a part of our Total Access Fund portfolio.

Alumni Ventures brings smart, simple venture capital to individual investors. Mike Collins, Founder and CEO of Alumni Ventures, discusses the inspiration for building the company and how it has grown, the community that provides AV its competitive advantage, and the lessons learned from building a disruptive company.

Product Lifecycle Management (PLM) systems allow companies to facilitate the entire lifecycle of a product, from engineering to design to manufacturing. PLM solutions help improve quality, reduce prototyping costs, and accelerate time to market. As a result, it is expected that the global PLM market will grow to $43.6 billion by 2028.

Alumni Ventures’ CEO Services team helps our portfolio companies take their next critical steps to success. We boost your business across our ecosystem of 600k+ community members comprising alumni and friends of the community from top U.S. universities (Harvard, Stanford, MIT, Yale, and others), leading VCs, experienced entrepreneurs, and C-suite executives from companies of all sizes and industries.

AV’s investment strategy is to co-invest alongside established lead VC firms. At exit, we seek to monetize our position expeditiously. At times, there might be exceptions, which are addressed below.

We are pleased to work with a variety of entrepreneurs and venture firms. As strict co-investors, we only invest when we believe we can add meaningful value to you. We welcome inquiries if you have an investment opportunity or just want to get acquainted.

Learn how Alumni Ventures evaluates a company for our fund portfolios.